Literature DB >> 1746682

Inflammatory fibrosarcoma of the mesentery and retroperitoneum. A tumor closely simulating inflammatory pseudotumor.

J M Meis1, F M Enzinger.   

Abstract

We report 38 cases of inflammatory fibrosarcoma occurring in 23 females and 15 males, 2 months to 74 years of age (median, 8.5 years; mean, 15 years) with symptoms of abdominal pain (17 cases), anemia (21 cases), fever (14 cases), mass (16 cases), and gastrointestinal obstruction (7 cases). Primary tumor sites included mesentery and retroperitoneum (31 cases), omentum (two cases), mediastinum (two cases), liver (one case), diaphragm (one case), and abdominal wall (one case). Sizes ranged from 2.4 cm to 20 cm (mean, 9.6 cm). Follow-up data in 27 cases revealed local recurrences in 10 patients, with multiple local recurrences in three and histologically proven distant metastases to lung (two cases) and brain (one case). Five patients died from their disease (median, 20 months). All tumors, including metastases, consisted of fibroblasts, myofibroblasts, and plasma cells, with variable degrees of fibrosis and calcification. Immunostains indicate myofibroblastic differentiation; 18 of 20 (90%) stained for actin, 15 of 18 (83%) for vimentin, and 10 of 13 (77%) for keratin (primarily in a submesothelial location). Ultrastructural studies also disclosed myofibroblastic features. The locally aggressive, recurrent nature of these neoplasms, as well as the occurrence of metastases and tumor deaths, indicate that they are potentially malignant neoplasms that we believe are better classified as inflammatory fibrosarcomas, not as cellular inflammatory pseudotumors.

Entities:  

Mesh:

Year:  1991        PMID: 1746682     DOI: 10.1097/00000478-199112000-00005

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  79 in total

1.  Sarcomatoid variant of anaplastic large cell lymphoma with cytoplasmic ALK and alpha-smooth muscle actin expression: a mimic of inflammatory myofibroblastic tumor.

Authors:  R Suzuki; M Seto; S Nakamura; A Nakagawa; K Hara; K Takeuchi
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors.

Authors:  B Lawrence; A Perez-Atayde; M K Hibbard; B P Rubin; P Dal Cin; J L Pinkus; G S Pinkus; S Xiao; E S Yi; C D Fletcher; J A Fletcher
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

3.  Soft-tissue inflammatory myofibroblastic tumors (IMTs) of the limbs: potential and limits of diagnostic imaging.

Authors:  Carlo Masciocchi; Giuseppe Lanni; Laura Conti; Armando Conchiglia; Eva Fascetti; Stefano Flamini; Gino Coletti; Antonio Barile
Journal:  Skeletal Radiol       Date:  2011-09-24       Impact factor: 2.199

4.  Mesenteric fibromatosis of the transverse colon with the reconstruction of the superior mesenteric arteries: report of a case.

Authors:  Makoto Seki; Rintaro Koga; Akio Saiura; Ken Nakagawa; Kazuyoshi Kawabata; Hiroaki Kanda; Mutsuo Machinami; Masaru Nakagawa
Journal:  Surg Today       Date:  2012-05-18       Impact factor: 2.549

5.  Regression of inflammatory myofibroblastic tumor of the gastrointestinal tract under infliximab treatment.

Authors:  Georgios Germanidis; Ioannis Xanthakis; Ioannis Tsitouridis; Thomas Zaramboukas; Dimitrios Kiskinis; Christos Konstantaras; Spiros Miliaras; Theodoros Sirakos; Emmanouil Pagkalos
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

Review 6.  Inflammatory pseudotumor of the cavernous sinus and skull base.

Authors:  Todd McCall; Daniel R Fassett; George Lyons; William T Couldwell
Journal:  Neurosurg Rev       Date:  2006-03-25       Impact factor: 3.042

7.  Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.

Authors:  James E Butrynski; David R D'Adamo; Jason L Hornick; Paola Dal Cin; Cristina R Antonescu; Suresh C Jhanwar; Marc Ladanyi; Marzia Capelletti; Scott J Rodig; Nikhil Ramaiya; Eunice L Kwak; Jeffrey W Clark; Keith D Wilner; James G Christensen; Pasi A Jänne; Robert G Maki; George D Demetri; Geoffrey I Shapiro
Journal:  N Engl J Med       Date:  2010-10-28       Impact factor: 91.245

8.  Unusual case of pancreatic inflammatory myofibroblastic tumor associated with spontaneous splenic rupture.

Authors:  Kamal S Hassan; Hector I Cohen; Fadi K Hassan; Shadi K Hassan
Journal:  World J Emerg Surg       Date:  2010-11-22       Impact factor: 5.469

9.  Pulmonary inflammatory myofibroblastic tumor after Hodgkin's lymphoma and application of PET imaging.

Authors:  R Howman-Giles; K London; G McCowage; N Graf; J Harvey
Journal:  Pediatr Surg Int       Date:  2008-06-05       Impact factor: 1.827

10.  Synchronous gastrointestinal and musculoskeletal manifestations of different subtypes of inflammatory myofibroblastic tumor: CT, MRI and pathological features.

Authors:  Marius Horger; Christina Pfannenberg; Michael Bitzer; Manfred Wehrmann; Claus D Claussen
Journal:  Eur Radiol       Date:  2004-08-21       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.